LEBOVITS CHAIM (See Remarks) purchased 41.7% of their position (23.84K shares) of BRAINSTORM CELL THERAPEUTICS INC. on the open market
Open‑market purchase worth $11.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/2/2024ACC: 0001104659-24-105215
Officer· See Remarks
Since Jul 2018
+23.84K
Net shares
Net buyer
$11.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
23.84K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22K
Price / share
$0.23
Trade value
$5.02K
% of position
1.9%
9/30/2024
1.16M→1.19M
Common Stock
Direct
Shares
+1.84K
Price / share
$3.43
Trade value
$6.29K
% of position
2.3%
10/1/2024
79.12K→80.96K
Total
Net shares
+23.84K
Net value
$11.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2024 | P · Purchase | +22K | $0.23 | $5.02K | 1.9% | 1.16M | 1.19M |
| Common Stock Direct | 10/1/2024 | P · Purchase | +1.84K | $3.43 | $6.29K | 2.3% | 79.12K | 80.96K |
| Total | +23.84K | $11.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned133.39K
Total
133.39K indirect133.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 133.39K | Indirect |
| Total | 133.39K | 133.39K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported